Circ_0001944 Contributes to Glycolysis and Tumor Growth by Upregulating NFAT5 Through Acting as a Decoy for miR-142-5p in Non-Small Cell Lung Cancer

References

• Alexander M, Kim SY, Cheng H. Update 2020: management of non-small cell lung cancer. Lung. 2020;198(6):897–907.33175991
   PubMed Web of Science ®Google Scholar
• Jin J, Robeson H, Fagan P, Orloff MS. Association of PARP1-specific polymorphisms and haplotypes with non-small cell lung cancer subtypes. PLoS One. 2020;15(12):e0243509.33284833
   PubMed Web of Science ®Google Scholar
• Heigener DF, Reck M. Lung cancer in 2017: giant steps and stumbling blocks. Nat Rev Clin Oncol. 2018;15(2):71–72.29158589
   PubMed Web of Science ®Google Scholar
• Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–385.31184787
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.21376230
   PubMed Web of Science ®Google Scholar
• Shankaraiah RC, Veronese A, Sabbioni S, Negrini M. Non-coding RNAs in the reprogramming of glucose metabolism in cancer. Cancer Lett. 2018;419:167–174.29366802
   PubMed Web of Science ®Google Scholar
• Hsiao KY, Sun HS, Tsai SJ. Circular RNA - New member of noncoding RNA with novel functions. Exp Biol Med (Maywood). 2017;242(11):1136–1141.28485684
   PubMed Web of Science ®Google Scholar
• Qu S, Yang X, Li X, et al. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015;365(2):141–148.26052092
   PubMed Web of Science ®Google Scholar
• Liang ZZ, Guo C, Zou MM, Meng P, Zhang TT. circRNA-miRNA-mRNA regulatory network in human lung cancer: an update. Cancer Cell Int. 2020;20:173.32467668
   PubMed Web of Science ®Google Scholar
• Verduci L, Strano S, Yarden Y, Blandino G. The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment. Mol Oncol. 2019;13(4):669–680.30719845
   PubMed Web of Science ®Google Scholar
• Wang H, Sun G, Xu P, et al. Circular RNA TMEM87A promotes cell proliferation and metastasis of gastric cancer by elevating ULK1 via sponging miR-142-5p. J Gastroenterol. 2021;56(2):125–138.33155080
   PubMed Web of Science ®Google Scholar
• Mao Y, He JX, Zhu M, Dong YQ, He JX. Circ0001320 inhibits lung cancer cell growth and invasion by regulating TNFAIP1 and TPM1 expression through sponging miR-558. Hum Cell. 2021;34(2):468–477.33128699
   PubMed Web of Science ®Google Scholar
• Jin M, Lu S, Wu Y, et al. Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548. J Exp Clin Cancer Res. 2020;39(1):186.32928266
   PubMed Web of Science ®Google Scholar
• Hang D, Zhou J, Qin N, et al. A novel plasma circular RNA circFARSA is a potential biomarker for non-small cell lung cancer. Cancer Med. 2018;7(6):2783–2791.29722168
   PubMed Web of Science ®Google Scholar
• Zhou L, Li M, Yu X, Gao F, Li W. Repression of Hexokinases II-mediated glycolysis contributes to piperlongumine-induced tumor suppression in non-small cell lung cancer cells. Int J Biol Sci. 2019;15(4):826–837.30906213
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab AF, Mahmoud W, Al-Harizy RM. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy. Pharmacol Res. 2019;150:104511.31678210
   PubMed Web of Science ®Google Scholar
• Pezzuto A, D’Ascanio M, Ricci A, Pagliuca A, Carico E. Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: a review. Thorac Cancer. 2020;11(11):3060–3070.32945604
   PubMed Web of Science ®Google Scholar
• Garcia SN, Guedes RC, Marques MM. Unlocking the Potential of HK2 in cancer metabolism and therapeutics. Curr Med Chem. 2019;26(41):7285–7322.30543165
   PubMed Web of Science ®Google Scholar
• Pathria G, Scott DA, Feng Y, et al. Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival. EMBO J. 2018;37(20):E99735.30209241
   PubMed Web of Science ®Google Scholar
• Fu B, Zhang A, Li M, et al. Circular RNA profile of breast cancer brain metastasis: identification of potential biomarkers and therapeutic targets. Epigenomics. 2018;10(12):1619–1630.30810051
   PubMed Web of Science ®Google Scholar
• Liu R, Zheng S, Yu K, et al. Prognostic value of miR-142 in solid tumors: a meta-analysis. Biosci Rep. 2021;41(2):BSR20204043.33600577
   PubMed Web of Science ®Google Scholar
• Yan J, Yang B, Lin S, Xing R, Lu Y. Downregulation of miR-142-5p promotes tumor metastasis through directly regulating CYR61 expression in gastric cancer. Gastric Cancer. 2019;22(2):302–313.30178386
   PubMed Web of Science ®Google Scholar
• Yu W, Li D, Zhang Y, et al. MiR-142-5p acts as a significant regulator through promoting proliferation, invasion, and migration in breast cancer modulated by targeting SORBS1. Technol Cancer Res Treat. 2019;18:1533033819892264.31789129
   PubMed Web of Science ®Google Scholar
• Guo J, Tang T, Li J, et al. Overexpression of miR-142-5p suppresses the progression of cervical cancer through targeting PIK3AP1 expression. Mol Cell Biol. 2020.
   Web of Science ®Google Scholar
• Liu L, Liu S, Duan Q, et al. MicroRNA-142-5p promotes cell growth and migration in renal cell carcinoma by targeting BTG3. Am J Transl Res. 2017;9(5):2394–2402.28559989
   PubMed Web of Science ®Google Scholar
• Liu S, Xiao Z, Ai F, et al. miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis. Biomed Pharmacother. 2017;92:1119–1127.28622713
   PubMed Web of Science ®Google Scholar
• Jiang Q, Xing W, Cheng J, Yu Y. Knockdown of lncRNA XIST suppresses cell tumorigenicity in human non-small cell lung cancer by regulating mir-142-5p/PAX6 axis. OncoTargets Ther. 2020;13:4919–4929.
   PubMed Web of Science ®Google Scholar
• Wang M, Shi J, Jiang H, Xu K, Huang Z. Circ_0014130 participates in the proliferation and apoptosis of nonsmall cell lung cancer cells via the miR-142-5p/IGF-1 axis. Cancer Biother Radiopharm. 2020;35(3):233–240.31916848
   PubMed Web of Science ®Google Scholar
• Prasad M, Brzostek J, Gautam N, Balyan R, Rybakin V, Gascoigne NRJ. Themis regulates metabolic signaling and effector functions in CD4 T cells by controlling NFAT nuclear translocation. Cell Mol Immunol. 2020.
   PubMed Web of Science ®Google Scholar
• Mognol GP, Carneiro FRG, Robbs BK, Faget DV, Viola JPB. Cell cycle and apoptosis regulation by NFAT transcription factors: new roles for an old player. Cell Death Dis. 2016;7:e2199.27100893
   PubMed Web of Science ®Google Scholar
• Küper C, Beck FX, Neuhofer W. NFAT5-mediated expression of S100A4 contributes to proliferation and migration of renal carcinoma cells. Front Physiol. 2014;5:293.25152734
   PubMed Web of Science ®Google Scholar
• Matsuda M, Katakura Y, Hirata M, et al. Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis. Lab Invest. 2014;16(5):454.
   Google Scholar
• Jiang Y, He R, Jiang Y, et al. Transcription factor NFAT5 contributes to the glycolytic phenotype rewiring and pancreatic cancer progression via transcription of PGK1. Cell Death Dis. 2019;10(12):948.31827081
   PubMed Web of Science ®Google Scholar
• Zhang S, Liao K, Miao Z, et al. CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5. Cell Death Dis. 2019;21(10):1284–1296.
   Google Scholar
• Cho HJ, Yun HJ, Yang HC, et al. Prognostic significance of nuclear factor of activated T-cells 5 expression in non-small cell lung cancer patients who underwent surgical resection. J Surg Res. 2018;226:40–47.29661287
   PubMed Web of Science ®Google Scholar
• Meng X, Li Z, Zhou S, Xiao S, Yu P. miR-194 suppresses high glucose-induced non-small cell lung cancer cell progression by targeting NFAT5. Thorac Cancer. 2019;10(5):1051–1059.30900402
   PubMed Web of Science ®Google Scholar